Intermittent weekly administration of human parathyroid hormone (1-34) improves bone-hydroxyapatite block bonding in ovariectomized rats

J Bone Miner Metab. 2010 Nov;28(6):634-40. doi: 10.1007/s00774-010-0178-z. Epub 2010 Apr 8.

Abstract

Hydroxyapatite (HA) blocks have been widely used for the reconstruction of bone defects and as a bone substitute. Bone-implant bonding depends on both implant-related factors and patient variables. Intermittent human parathyroid hormone (h-PTH) has a strong anabolic effect on bone formation. The purpose of the present study is to evaluate whether intermittent h-PTH administration enhances bone-HA block bonding in normal versus ovariectomized (OVX) rats. Cancellous bone osteotomy and HA-block implantation were performed on the proximal left tibia in both OVX and sham-operated 7-month-old female Sprague-Dawley rats. Newly formed cancellous bone around the HA block and bone-HA block bonding were evaluated by bone histomorphometry at 8 weeks after the administration of h-PTH (100 μg/kg/week) or its vehicle. The administration of h-PTH significantly increased cancellous bone volume by stimulating bone formation in OVX rats (p < 0.01). Although bone-HA block bonding was significantly decreased in OVX rats compared to that of sham-operated rats (p < 0.01), h-PTH improved the bone-HA block bonding in OVX rats (p < 0.01). These results suggest that intermittent h-PTH treatment may improve bone-HA bonding in osteoporosis by restoring cancellous bone volume and enhancing cancellous bone formation around the HA block.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Bone Density Conservation Agents / administration & dosage*
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Resorption / prevention & control
  • Bone Substitutes / therapeutic use*
  • Durapatite / therapeutic use*
  • Female
  • Humans
  • Knee
  • Osteogenesis / drug effects
  • Osteoporosis / drug therapy
  • Osteoporosis / pathology
  • Osteoporosis / therapy
  • Osteoporosis, Postmenopausal / drug therapy*
  • Osteoporosis, Postmenopausal / pathology
  • Osteoporosis, Postmenopausal / therapy
  • Ovariectomy
  • Rats
  • Rats, Sprague-Dawley
  • Teriparatide / administration & dosage*
  • Teriparatide / therapeutic use*
  • Tibia / drug effects
  • Tibia / pathology

Substances

  • Bone Density Conservation Agents
  • Bone Substitutes
  • Teriparatide
  • Durapatite